Iowa Lottery Action, April 17-30, 2006, vol. 13, no. 8

Iowa Lottery newsletter for Lottery retailers.

Iowa Lottery Action, March 6-19, 2006, vol. 13, no. 5

Iowa Lottery newsletter for Lottery retailers.

Iowa Lottery Action, June 5-18, 2006, Vol. 13, no. 11

Iowa Lottery newsletter for Lottery retailers.

Iowa Lottery Action, June 19-July 9, 2006, Vol. 13, no. 12

Iowa Lottery newsletter for Lottery retailers.

Lottery Action Newsletter, July 10-23, 2006, Vol. 13, no. 13

Iowa Lottery Authority Retailer Newsletter

Lottery Action Newsletter, July 24-Aug. 8, 2006, Vol 13, no. 14

Iowa Lottery Retailer Newsletter

Lottery Action Newsletter, Aug. 7-10, 2006, Vol. 13, no. 15

Iowa Lottery Retailer Newsletter

Lottery Action Newsletter, Aug. 21-Sept. 10, 2006, Vol. 13, no. 16

Iowa Lottery Retailer Newsletter

Lottery Action Newsletter, September 9-24, 2006, Vol. 13, no. 17

Iowa Lottery Retailer Newsletter

Lottery Action Newsletter, September 25-October 8, 2006, Vol. 13, no. 18

Iowa Lottery Retailer Newsletter

Lottery Action Newsletter, October 9-22, 2006, Vol. 13, no. 19

Iowa Lottery Retailer Newsletter

Lottery Action Newsletter, October 23-November 12, 2006, Vol. 13, no. 20

Iowa Lottery Retailer Newsletter

Fenofibrate: a new treatment for diabetic retinopathy. Molecular mechanisms and future perspectives.

Despite improving standards of care, people with diabetes remain at risk of development and progression of diabetic retinopathy (DR) and visual impairment. Identifying novel therapeutic approaches, preferably targeting more than one pathogenic pathway in DR, and at an earlier stage of disease, is attractive. There is now consistent evidence from two major trials, the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study and the Action to Control Cardiovascular Risk in Diabetes Eye (ACCORD-Eye) study, totalling 11,388 people with type 2 diabetes (5,701 treated with fenofibrate) that fenofibrate reduces the risk of development and progression of DR. Therefore, fenofibrate may be considered a preventive strategy for patients without DR or early intervention strategy for those with mild DR. A number of putative therapeutic mechanisms for fenofibrate, both dependent and independent of lipids, have been proposed. A deeper understanding of the mode of action of fenofibrate will further help to define how best to use fenofibrate clinically as an adjunct to current management of DR.

Community Action in Iowa, 2005

The Division of Community Action Agencies is located within the Iowa Department of Human Rights and is the focal point for Community Action Agency activities within Iowa government. The Division of Community Action Agencies exists to develop and expand the capacity at the community level to assist families and individuals to achieve economic and social self-sufficiency, and to ensure that the basic energy needs of Iowa’s low-income population are met. The Division is comprised of the Bureau of Community Services, the Bureau of Energy Assistance and the Bureau of Weatherization.